KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables Refunds
Ratios

Astrana Health (ASTH) Depreciation & Amortization (IS) (2016 - 2025)

Astrana Health's Depreciation & Amortization (IS) history spans 12 years, with the latest figure at $15.6 million for Q3 2025.

  • For Q3 2025, Depreciation & Amortization (IS) rose 114.69% year-over-year to $15.6 million; the TTM value through Sep 2025 reached $37.5 million, up 51.7%, while the annual FY2024 figure was $27.9 million, 57.35% up from the prior year.
  • Depreciation & Amortization (IS) for Q3 2025 was $15.6 million at Astrana Health, up from $6.9 million in the prior quarter.
  • Across five years, Depreciation & Amortization (IS) topped out at $15.6 million in Q3 2025 and bottomed at $4.1 million in Q4 2022.
  • The 5-year median for Depreciation & Amortization (IS) is $4.7 million (2021), against an average of $5.8 million.
  • The largest YoY upside for Depreciation & Amortization (IS) was 137.7% in 2021 against a maximum downside of 10.74% in 2021.
  • A 5-year view of Depreciation & Amortization (IS) shows it stood at $4.4 million in 2021, then fell by 7.91% to $4.1 million in 2022, then rose by 20.65% to $4.9 million in 2023, then soared by 65.77% to $8.1 million in 2024, then skyrocketed by 91.91% to $15.6 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Depreciation & Amortization (IS) are $15.6 million (Q3 2025), $6.9 million (Q2 2025), and $6.8 million (Q1 2025).